MAXXEUS ALLOGRAFT HUMAN PRODUCT W81K0025QA147
Summary
AI-generated · Sep 12, 2025Provide four line-item packages of FDA-approved, AATB-certified, and TJC-regulated allograft tissues: allograft human skin tissue and costal cartilage tissue (each item size <= 0.8 cm) with 12 units per item, corresponding to part numbers 4936-25, 4935-25, 4929-25, and 4938-25. The supplier must meet FDA, AATB, and TJC standards and comply with Army Medical Command rules, offering a range of tissues, allografts, and related surgical supplies (including safe biologic, metal, and synthetic implants). Deliveries must be expedited, with delivery within 24 hours of order, and the vendor should provide clinical solutions for wound management, reconstructive surgery, abdominal and incisional care, among other items.
Contract type is firm-fixed-price; award will be made on a lowest-price technically acceptable basis, ensuring best value and a fair, reasonable price. To obtain the full solicitation, email a request.
FOR A COPY OF THE FULL SOLICITATION, PLEASE SEND AN EMAIL REQUEST FDA approved, AATB and TJC compliant Allograft Human Skin Tissue Costal Cartilage Allograft Human Skin Tissue Costal Cartilage (2) <= 0.8 cm 4936-25 QTY 12 each Allograft Human Skin Tissue Costal Cartilage (2) <= 0.8 cm 4935-25 QTY 12 each Allograft Human Skin Tissue Costal Cartilage (2) <= 0.8 cm 4929-25 QTY 12 each Allograft Human Skin Tissue Costal Cartilage (2) <= 0.8 cm 4938-25 QTY 12 each Salient Characteristics: - Must be Food and Drug Administration (FDA), American Association of Tissue Banks (AATB), and regulated by The Joint Commission (TJC) compliant. - Must be able to meet standards set forth by the FDA, AATB and TJC and conform to the rules and regulations set forth by the Army Medical Command. - Must be able to provide a myriad of different tissues, allografts, and supplies associated with surgery. - May provide safe biologic, metal, and synthetic implants. - Must provide clinical solutions to wound management, reconstructive surgery, abdominal, and incisional management, but not limited to the items previous cited in the memorandum. - Must have expediated delivery. Must be able to deliver within 24 hours of receiving an order. The Government will award a Firm-Fixed-Price (FFP) contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation is the best value to the Government and provides fair and reasonable price. The quote shall conform to the solicitation and be advantageous to the Government. Award will be made using the Lowest Price Technically Acceptable (LPTA) process.
From Solicitation posted on Sep 11, 2025FDA approved, AATB and TJC compliant Maxxeus Allograft Human Product Maxxues Allograft Costal Cartilage (2) <= 0.8 cm 4936-25 QTY 12 each Maxxues Allograft Costal Cartilage (2) <= 0.8 cm 4935-25 QTY 12 each Maxxues Allograft Costal Cartilage (2) <= 0.8 cm 4929-25 QTY 12 each Maxxues Allograft Costal Cartilage (2) <= 0.8 cm 4938-25 QTY 12 each Salient Characteristics: - Must be Food and Drug Administration (FDA), American Association of Tissue Banks (AATB), and regulated by The Joint Commission (TJC) compliant. - Must be able to meet standards set forth by the FDA, AATB and TJC and conform to the rules and regulations set forth by the Army Medical Command. - Must be able to provide a myriad of different tissues, allografts, and supplies associated with surgery. - May provide safe biologic, metal, and synthetic implants. - Must provide clinical solutions to wound management, reconstructive surgery, abdominal, and incisional management, but not limited to the items previous cited in the memorandum. - Must have expediated delivery. Must be able to deliver within 24 hours of receiving an order. The Government will award a Firm-Fixed-Price (FFP) contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation is the best value to the Government and provides fair and reasonable price. The quote shall conform to the solicitation and be advantageous to the Government. Award will be made using the Lowest Price Technically Acceptable (LPTA) process.
From Solicitation posted on Sep 15, 2025Notice history
2-
-
Solicitation LATEST Posted Sep 15, 2025View changes (3)
- Title: Allograft Human Skin Tissue → MAXXEUS ALLOGRAFT HUMAN PRODUCT
- Description: Description was updated
- Response Deadline: Sep 16, 2025 → Sep 17, 2025
Details
Award Information
Not yet awarded
Contacts
Agency
Place of Performance
USA